These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25470688)

  • 1. Identification of a preoperative predictive factor for lymph node metastasis in uterine papillary serous carcinoma: long-term results from a single institution.
    Baek MH; Lee SW; Park JY; Kim D; Kim JH; Kim YM; Kim YT; Nam JH
    Int J Gynecol Cancer; 2015 Jan; 25(1):69-74. PubMed ID: 25470688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extrauterine Spread, Adjuvant Treatment, and Prognosis in Noninvasive Uterine Papillary Serous Carcinoma of the Endometrium: A Retrospective Multicenter Study.
    Boyraz G; Salman MC; Basaran D; Ozgul N; Turan T; Turkmen O; Kimyon GC; Ozkan NT; Cagan M; Gungor T; Meydanli MM; Gungorduk K; Gulseren V; Sanci M; Yuce K
    Int J Gynecol Cancer; 2017 Jan; 27(1):102-108. PubMed ID: 27668395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry.
    Mattes MD; Lee JC; Metzger DJ; Ashamalla H; Katsoulakis E
    J Gynecol Oncol; 2015 Jan; 26(1):19-24. PubMed ID: 25310855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer Antigen 125 Levels are Significantly Associated With Prognostic Parameters in Uterine Papillary Serous Carcinoma.
    Schmidt M; Segev Y; Sadeh R; Suzan E; Feferkorn I; Kaldawy A; Kligun G; Lavie O
    Int J Gynecol Cancer; 2018 Sep; 28(7):1311-1317. PubMed ID: 29958235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Metastatic Regional Lymph Node Locations and Predictors of Para-aortic Lymph Node Involvement in Endometrial Cancer Patients at Risk for Lymphatic Dissemination.
    Altay A; Toptas T; Dogan S; Simsek T; Pestereli E
    Int J Gynecol Cancer; 2015 May; 25(4):657-64. PubMed ID: 25647255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of pre-operative serum CA-125 in the management of uterine papillary serous carcinoma.
    Olawaiye AB; Rauh-Hain JA; Withiam-Leitch M; Rueda B; Goodman A; del Carmen MG
    Gynecol Oncol; 2008 Sep; 110(3):293-8. PubMed ID: 18644620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy.
    Sueoka K; Umayahara K; Abe A; Usami T; Yamamoto A; Nomura H; Matoda M; Okamoto S; Omatsu K; Kondo E; Kato K; Takeshima N
    Int J Gynecol Cancer; 2015 Jan; 25(1):81-6. PubMed ID: 25347094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Para-aortic lymphadenectomy in the management of preoperative grade 1 endometrial cancer confined to the uterine corpus.
    Yoon JH; Yoo SC; Kim WY; Chang SJ; Chang KH; Ryu HS
    Ann Surg Oncol; 2010 Dec; 17(12):3234-40. PubMed ID: 20585865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution and volume of extrauterine disease in uterine serous carcinoma: is minimally invasive surgery a suitable approach?
    Ayeni TA; AlHilli MM; Bakkum-Gamez JN; Mariani A; McGree ME; Weaver AL; Cliby WA; Keeney GL; Podratz KC; Dowdy SC
    Int J Gynecol Cancer; 2015 Jan; 25(1):87-91. PubMed ID: 25474625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of preoperative criteria used to predict lymph node metastasis in endometrial cancer.
    Han SS; Lee SH; Kim DH; Kim JW; Park NH; Kang SB; Song YS
    Acta Obstet Gynecol Scand; 2010; 89(2):168-74. PubMed ID: 19916890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma.
    Thomas MB; Mariani A; Cliby WA; Keeney GA; Podratz KC; Dowdy SC
    Gynecol Oncol; 2007 Nov; 107(2):186-9. PubMed ID: 17688926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine papillary serous carcinoma: patterns of metastatic spread.
    Goff BA; Kato D; Schmidt RA; Ek M; Ferry JA; Muntz HG; Cain JM; Tamimi HK; Figge DC; Greer BE
    Gynecol Oncol; 1994 Sep; 54(3):264-8. PubMed ID: 8088602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative MRI and intraoperative frozen section diagnosis of myometrial invasion in patients with endometrial cancer.
    Tanaka T; Terai Y; Ono YJ; Fujiwara S; Tanaka Y; Sasaki H; Tsunetoh S; Kanemura M; Yamamoto K; Yamada T; Ohmichi M
    Int J Gynecol Cancer; 2015 Jun; 25(5):879-83. PubMed ID: 25950131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel multivariable prediction model for lymphatic dissemination in endometrioid endometrial cancer: The lymph node Metastasis Risk Index.
    Meydanli MM; Aslan K; Oz M; Muftuoglu KH; Yalcin I; Engin-Ustun Y
    Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():310-315. PubMed ID: 31377459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal disseminated recurrence and lung metastasis after surgery for stage IA uterine papillary serous carcinoma of the endometrium: a case report.
    Kanayama S; Yamada Y; Haruta S; Naruse K; Furukawa N; Kawaguchi R; Yoshida S; Sakata M; Sado T; Kitanaka T; Oi H; Kobayashi H
    Arch Gynecol Obstet; 2008 Sep; 278(3):277-80. PubMed ID: 18193438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative Prediction of Cardiophrenic Lymph Node Metastasis in Advanced Ovarian Cancer Using Computed Tomography.
    Kim TH; Lim MC; Kim SI; Seo SS; Kim SH; Park SY
    Ann Surg Oncol; 2016 Apr; 23(4):1302-8. PubMed ID: 26714941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (Stage I-III) disease.
    Bristow RE; Asrari F; Trimble EL; Montz FJ
    Gynecol Oncol; 2001 May; 81(2):279-86. PubMed ID: 11330963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uterine papillary serous carcinoma pre-operatively diagnosed as endometrioid carcinoma: Is omentectomy necessary?
    Peled Y; Aviram A; Krissi H; Gershoni A; Sabah G; Levavi H; Eitan R
    Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):498-502. PubMed ID: 26235227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterine papillary serous carcinoma. A clinical study.
    Gitsch G; Friedlander ML; Wain GV; Hacker NF
    Cancer; 1995 May; 75(9):2239-43. PubMed ID: 7712431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of lymphedema incidence between 2 lymphadenectomy techniques in patients with uterine cancer undergoing robotic staging.
    Menderes G; Azodi M; Schwartz P; Silasi DA
    Int J Gynecol Cancer; 2015 Jan; 25(1):160-5. PubMed ID: 25386859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.